Physician profile
Anthony S Lapinsky
NPI 1518931971
$29,030.69
in general payments reported to CMS, 2019-2025
10 companies · $974 in 2025
The $974 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $2,752 · 2021: $1,700 · 2022: $645 · 2023: $1,538 · 2024: $4,018 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,243 · Royalty Or License: $1,323 · Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,242.75 |
| Royalty Or License | $1,322.72 |
| Food and Beverage | $965.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $21,394.39 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $4,621.21 | 2019-2024 | Avenir, Persona, Rosa |
| Stryker Corporation | $1,510.38 | 2024-2025 | Mako, Pro, Axsos |
| Xtant Medical INC | $1,322.72 | 2023-2025 | |
| Medtronic, INC. | $58.36 | 2022 | |
| Depuy Synthes Sales INC. | $43.13 | 2025 | Na |
| Boston Scientific Corporation | $21.89 | 2019 | |
| Endo Pharmaceuticals INC. | $20.73 | 2020 | |
| Pfizer INC. | $20.39 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $17.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lapinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.